about
Nanomedicine in Central Nervous System (CNS) Disorders: A Present and Future ProspectiveEndogenous repair signaling after brain injury and complementary bioengineering approaches to enhance neural regenerationBrain Uptake of Neurotherapeutics after Intranasal versus Intraperitoneal Delivery in Mice.Nano-enabled delivery of diverse payloads across complex biological barriers.The novel synthetic microneurotrophin BNN27 protects mature oligodendrocytes against cuprizone-induced death, through the NGF receptor TrkA.Nanoneurotherapeutics approach intended for direct nose to brain delivery.Polymer-based vehicles for therapeutic peptide delivery.Spatiotemporal presentation of exogenous SDF-1 with PLGA nanoparticles modulates SDF-1/CXCR4 signaling axis in the rodent cortex.The role of human endogenous retroviruses in brain development and function.Exercise as Gene Therapy: BDNF and DNA Damage Repair.Biophysical and Computational Studies of the vCCI:vMIP-II Complex.Pluronic F127 and D-α-Tocopheryl Polyethylene Glycol Succinate (TPGS) Mixed Micelles for Targeting Drug Delivery across The Blood Brain Barrier.Anti-cancer Antibody Trastuzumab-Melanotransferrin Conjugate (BT2111) for the Treatment of Metastatic HER2+ Breast Cancer Tumors in the Brain: an In-Vivo Study.Early sites of virus replication after oral SIVmac251 infection of infant macaques: implications for pathogenesis.An Implantable Micro-Caged Device for Direct Local Delivery of Agents.Dibutyryl Cyclic Adenosine Monophosphate Rescues the Neurons From Degeneration in Stab Wound and Excitotoxic Injury Models
P2860
Q28075999-A4299F00-9791-47DE-AEA1-2B3D5AC2605CQ35600150-3D945BCA-726E-4635-B0A7-F1C70340D0ECQ36052412-7D7DC20D-FE6E-45F6-A4B4-99B48229E959Q36307467-021CF66F-0274-4789-A4A0-1316718D950EQ36388390-B39C9857-D07F-4AD4-ADD7-6492D2734AA9Q38522125-89299274-80E0-4528-836F-6A2CF7E5553CQ38645362-3D716338-20D9-49D9-A030-CBB3E27F33D2Q38681163-D4832DD9-FCA1-4039-84FA-FA17341A0447Q38714227-1309B4D4-20E0-4874-9AAF-A2EAD6C8932AQ38917397-599C1097-1858-4C21-9078-9BD3122D9CD0Q40081462-CBA35D4C-1952-4E9D-8A41-A1FEF0310EE2Q42215950-E33C879E-4C89-4F29-B205-EB6D162FBA6FQ44844636-EF23DE39-F981-4B8A-9D84-F1C47082505DQ46046314-7CB57BC2-935B-48BE-8D73-33BF749B331FQ47098539-307066AE-7C51-4AA1-89C3-EDC646E56633Q58795488-3D22D3AD-22C4-4536-A937-1BDF9BC903CF
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Agile delivery of protein therapeutics to CNS
@ast
Agile delivery of protein therapeutics to CNS
@en
Agile delivery of protein therapeutics to CNS
@nl
type
label
Agile delivery of protein therapeutics to CNS
@ast
Agile delivery of protein therapeutics to CNS
@en
Agile delivery of protein therapeutics to CNS
@nl
prefLabel
Agile delivery of protein therapeutics to CNS
@ast
Agile delivery of protein therapeutics to CNS
@en
Agile delivery of protein therapeutics to CNS
@nl
P2093
P2860
P1476
Agile delivery of protein therapeutics to CNS
@en
P2093
Anna Brynskikh
Devika S Manickam
P2860
P304
P356
10.1016/J.JCONREL.2014.06.017
P407
P50
P577
2014-06-21T00:00:00Z